Anticancer Drug Development
- 8 June 2009
- book chapter
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- Endpoints for Assessing Drug Activity in Clinical TrialsThe Oncologist, 2008
- Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug ScreenCancer Research, 2008
- Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for CancerThe American Journal of Pathology, 2007
- Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cellsExperimental Neurology, 2006
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- The role of pharmacogenetics in cancer therapeuticsBritish Journal of Clinical Pharmacology, 2006
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorThe New England Journal of Medicine, 1992
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)The New England Journal of Medicine, 1948